InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (26 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
26
T+90 hit rate
75%
T+90 mean return
+6.6%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by ALTSHULER DAVID, Directeur Exécutif, Recherche Globale et Directeur Scientifique. Director active across 2 companies, notably VERTEX PHARMACEUTICALS INC / MA. Cumulatively, 51 reports have been logged. Split: 0 buy · 26 sells. Total volume traded: €12.4m. Activity tracked since 17 May 2021. The latest transaction was filed on 15 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations51 total
▼
52 shares@ US$424.690.1% of flowCommon StockSEC:0000875320-25-000201:0
3,231 shares@ US$510.004.6% of flowCommon StockSEC:0000875320-25-000152:0
3,231 shares@ US$500.004.5% of flowCommon StockSEC:0000875320-25-000144:0
3,231 shares@ US$490.004.6% of flowCommon StockSEC:0000875320-25-000139:0
5,954 shares@ US$479.618.3% of flowCommon StockSEC:0000875320-25-000120:0
3,971 shares@ US$483.285.6% of flowCommon StockSEC:0000875320-25-000101:0
▼
1,111 shares@ US$480.001.6% of flowCommon StockSEC:0000875320-25-000099:0
2,293 shares@ US$463.463.1% of flowCommon StockSEC:0000875320-25-000077:0
5,324 shares0Common StockSEC:0000875320-25-000055:0
2,142 shares@ US$467.983.0% of flowCommon StockSEC:0000875320-25-000031:0
12,314 shares0Common StockSEC:0000875320-25-000005:0
15 shares@ US$478.560.0% of flowCommon StockSEC:0000875320-24-000229:0
▼
54 shares@ US$430.930.1% of flowCommon StockSEC:0000875320-24-000150:0
3,970 shares@ US$431.794.8% of flowCommon StockSEC:0000875320-24-000095:0
4,239 shares@ US$425.705.1% of flowCommon StockSEC:0000875320-24-000095:1
3,002 shares@ US$421.773.6% of flowCommon StockSEC:0000875320-24-000085:0
3,750 shares@ US$424.014.5% of flowCommon StockSEC:0000875320-24-000066:0
●
2,099 shares@ US$422.742.5% of flowCommon StockSEC:0000875320-24-000039:0
3,145 shares@ US$420.243.7% of flowCommon StockSEC:0000875320-24-000039:1
5,814 shares0Common StockSEC:0000875320-24-000014:0
19 shares@ US$369.920.0% of flowCommon StockSEC:0000875320-23-000039:0
63 shares@ US$345.510.1% of flowCommon StockSEC:0000899243-23-018044:0
3,970 shares@ US$289.123.3% of flowCommon StockSEC:0001209191-23-013685:0
3,636 shares@ US$287.233.0% of flowCommon StockSEC:0001209191-23-013685:1
300 shares@ US$288.740.2% of flowCommon StockSEC:0001209191-23-013685:2
25 of 51 declarations
About ALTSHULER DAVID
David Altschuler is Executive Vice President of Global Research and Chief Scientific Officer at Vertex Pharmaceuticals Inc., a biopharmaceutical company. In this role, he oversees research and development efforts, contributing to innovation in the treatment of serious diseases.
